24-hour efficacy of once-daily diltiazem in essential hypertension

B M Massie1, E Der, T S Herman

  • 1University of California, San Francisco.

Insights

This study shows that a new once-daily diltiazem hydrochloride extended-release formulation (diltiazem CD) effectively lowers blood pressure in patients with essential hypertension over a 24-hour period.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Essential hypertension is a widespread condition requiring effective long-term management.
  • Diltiazem hydrochloride is a calcium channel blocker used to treat hypertension.
  • Evaluating new formulations for improved patient compliance and sustained efficacy is crucial.

Purpose of the Study:

  • To assess the safety and effectiveness of a novel once-daily diltiazem hydrochloride extended-release formulation (diltiazem CD).
  • To determine if diltiazem CD provides 24-hour blood pressure control in patients with essential hypertension.

Main Methods:

  • A randomized, placebo-controlled trial involving 127 patients with essential hypertension.
  • Patients received either diltiazem CD (n=61) or placebo (n=66), with dose titration up to 360 mg/day.
  • Ambulatory blood pressure monitoring was used in a subset of patients to evaluate 24-hour efficacy.

Main Results:

  • Diltiazem CD significantly reduced supine systolic blood pressure (SBP) by -8.4 mmHg and diastolic blood pressure (DBP) by -8.6 mmHg (p<0.0075).
  • Heart rate remained largely unchanged, indicating a favorable safety profile.
  • Sixty-nine percent of patients achieved a clinical response, and 24-hour blood pressure control was demonstrated.

Conclusions:

  • Once-daily diltiazem CD is a safe and effective treatment for essential hypertension.
  • The formulation provides sustained 24-hour blood pressure reduction, supporting its use for improved patient adherence.

Related Concept Videos

Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...